Ascentage Pharma Group International AAPG
NASDAQ AAPG
$15.24 -0.26 (-1.68%)
As of: Nov 11, 2026 · 3:59 PM EST

Ascentage Pharma Group International (AAPG) Current Assets (2023 - 2026)

Updated

Ascentage Pharma Group International's Current Assets was $337.99 million in Q2 2026, up 26.8% from $266.45 million a year earlier.

Analysis

Ascentage Pharma Group International (AAPG) Current Assets (2023 - 2026) Analysis & Trends

At the end of FY2025, Current Assets at Ascentage Pharma Group International came in at $421.01 million, up 108.5% from FY2024.

  • In earlier years, Current Assets was $201.96 million in FY2024 (+6.8%) and $189.13 million in FY2023.
  • Quarterly Current Assets has moved between $189.13 million (Q4 2023) and $420.83 million (Q4 2025) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 65.26 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 56.35 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 37.48 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 38.94 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 31.45 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 34.36 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 16.55 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 45.01 Bn
10 Ascentage Pharma Group International 1.42 Bn 382.83 Mn - 337.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 337.99 Mn
Dec 31, 2025 420.83 Mn
Jun 30, 2025 266.45 Mn
Dec 31, 2024 201.99 Mn
Dec 31, 2023 189.13 Mn
API Access

Ascentage Pharma Group International Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=AAPG&period=max&api_key=YOUR_API_KEY